Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Gen-Probe, Incorporated
Gen-Probe, Incorporated
Industry · 13 registered clinical trials.
Status
Trial
Phase
Started
Completed
Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay
HIV-1 Infection
—
2014-01-01
Completed
Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - CTS
Dengue
—
2013-01-01
Terminated
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Chlamydia Infections, Gonorrhea, Trichomonas Infections
—
2013-01-01
Completed
Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System
Human Papillomavirus Infection
—
2012-10-01
Completed
Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican Blood Donors - American Red
Dengue
—
2012-08-01
Completed
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Ass
Trichomonas Vaginalis
—
2012-08-01
Completed
Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ System
Human Papilloma Virus Infection
—
2012-03-01
Completed
Prospective Collection of Female and Male Specimens for PANTHER® System Testing
Chlamydia Infections, Gonorrhea
—
2012-02-01
Completed
APTIMA HPV 16 18/45 Genotype Assay on the TIGRIS DTS System in Women With ASC-US or Negative Pap Test Results
Human Papillomavirus Infection
—
2011-06-01
Withdrawn
Clinical Evaluation of the APTIMA® Assay for Chlamydia Trachomatis Using the PANTHER™ System
Chlamydia Trachomatis
—
2010-11-01
Completed
Clinical Evaluation of the APTIMA® COMBO 2® Assay Using the PANTHER™ System
Chlamydia Trachomatis, Neisseria Gonorrhoeae Infection
—
2010-11-01
Completed
Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Pr
Prostatic Neoplasms
N/A
2009-08-01
Completed
Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System
Human Papillomavirus Infection
Phase 3
2008-03-01